Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2006
11/29/2006CN1286481C Embrocation for treating allergic rhinitis
11/29/2006CN1286477C Externally applied plaster for treating respiratory tract infection
11/29/2006CN1286460C Application of sophocarpine on preparing medication for curing disease caused by coronavirus
11/29/2006CN1286457C Freeze-dried powder injection of andrographolide and preparation thereof
11/29/2006CN1286452C Chicken gallbladder extractum dispersible tablet and its preparation process
11/28/2006US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
11/28/2006US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin
11/28/2006US7141590 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
11/28/2006US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006US7141555 Water solubility, bioavailability, oral administration; unit dosage
11/28/2006US7141542 Biologically active protein useful for aerosol delivery to the respiratory tract
11/28/2006US7141365 Methods for diagnosing a mucin production associated disease condition
11/28/2006CA2379786C Purine derivatives
11/28/2006CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006CA2268305C Use of an h+, k+-atpase inhibitor in the treatment of nasal polyps
11/28/2006CA2239853C Indane dimer compounds and their pharmaceutical use
11/28/2006CA2160444C Aroyl-piperdine derivatives
11/23/2006WO2006125132A2 Aerosolized fluoroquinolones and uses thereof
11/23/2006WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006WO2006123639A1 Pyrimidine derivative
11/23/2006WO2006123125A1 Combinations of statins with glucocorticosteroids
11/23/2006WO2006122788A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
11/23/2006WO2006071538A3 Substituted biaryl analogues
11/23/2006US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006US20060264436 Method of Treating a Psychotic Disorder
11/23/2006US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006US20060263781 Regulation of cell surface proteins
11/23/2006US20060263447 Treating pulmonary disorders with gaseous agent causing repletion of GSNO
11/23/2006US20060263422 Pharmaceutical composition containing decoy and use of the same
11/23/2006US20060263359 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
11/23/2006DE102005023993A1 Nicht virales Vektorsystem zum Transport von Nukleinsäure in die Lunge Non-viral vector system for transporting nucleic acid into the lungs
11/23/2006DE102005023207A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease
11/23/2006DE102005022845A1 Thiobernsteinsäurederivate und deren Verwendung Thiobernsteinsäurederivate and their use
11/23/2006CA2608752A1 Formulations for alteration of biophysical properties of mucosal lining
11/23/2006CA2608493A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor
11/23/2006CA2608273A1 Aerosolized fluoroquinolones and uses thereof
11/23/2006CA2607472A1 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/22/2006EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006EP1724267A1 Pyrimidine derivative
11/22/2006EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006EP1723136A1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
11/22/2006EP1723121A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
11/22/2006EP1723115A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006EP1723113A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006EP1723112A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006EP1723111A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006EP1723110A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006EP1723109A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006EP1723108A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006EP1723105A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
11/22/2006EP1722771A1 Compositions and methods for preventing or treating an inflammatory response
11/22/2006EP1722767A2 NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
11/22/2006EP1509520B1 Use of benzo(c)quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
11/22/2006EP1474131B1 Use of anethole dithiolethione in lung cancer chemoprevention
11/22/2006EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006EP1461034B1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
11/22/2006EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006EP1401413B1 Use of tyrosine kinase inhibitions for treating allergic diseases
11/22/2006EP1360186B1 Carboline derivatives
11/22/2006EP1351933B1 Il-8 receptor antagonists
11/22/2006EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006EP1051395B1 N-hydroxyformamide derivatives
11/22/2006EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006CN1867577A Estratriene derivatives
11/22/2006CN1867339A Novel use of cannabinoid receptor agonist
11/22/2006CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006CN1864740A A Chinese medicinal composition for clearing heat and expelling toxin and preparation method thereof
11/22/2006CN1864713A Spray for treating influenza and preparation method thereof
11/22/2006CN1864712A A Chinese medicine for treating rhinitis and preparation method thereof
11/22/2006CN1864696A New formulation
11/22/2006CN1864692A A drug action released evenly sustained release capsule of benproperine phosphate
11/22/2006CN1864684A Lyophilized powder injection of doxofylline and preparation method thereof
11/22/2006CN1864679A A composite bergenin dispersible tablet and preparation method thereof
11/22/2006CN1864672A A solid dispersion of ambroxol hydrochloride and composition thereof
11/22/2006CN1864565A Health smoke substitute making cactus as main raw material
11/22/2006CN1285586C Tectoridin isoflavone derivatives, their preparation process, and anti-virus medicines with tectoridin isoflavone derivatives as active components
11/22/2006CN1285572C Cannabinod receptor ligands
11/22/2006CN1285382C Nasal administered drug delivery system containing mycose and hyaluronic acid and method for preparing same
11/22/2006CN1285371C Plant liquor for removing heat from lung to relieve cough
11/22/2006CN1285360C Medicine compound having synergistic action
11/21/2006US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
11/21/2006US7138507 primers for amplification of GST-pi mRNA in fixed and paraffin-embedded (FPE) tumor tissue; use in pharmacogenetics
11/21/2006US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006US7138420 Substituted benzimidazole compounds
11/21/2006US7138417 Inhibitors of integrin αvβ6
11/21/2006US7138416 Compounds and therapeutic uses thereof
11/21/2006US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006US7138398 Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them
11/21/2006US7138275 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use